NEWS
Stocktwits Top 25 - Week 08

Welcome to the Stocktwits Top 25 Newsletter for Week 08 of 2024!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time. 

Here are the Stocktwits Top 25 Lists for Week 08:

P.S. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!

S&P 500
ST Top 25 S&P 500

The S&P 500 Top 25 list (+2.04%) outperformed the S&P 500 index (+1.66%).

There were 3 major changes to the list this week.

Tech stocks continue to dominate the list, with sentiment scores also ticking down across the board. Could the Stocktwits community be anticipating a change of trend in the market? 

Check out how the momentum meter has performed vs. the S&P 500 index this year:

NASDAQ 100
The Large-Cap Nasdaq 100

The Nasdaq 100 Top 25 list (+1.42%) performed exactly in line with the Nasdaq 100 index (+1.42%). We've never seen that before, so we had to double-check the numbers real quick, lol.

There were 5 major changes to the list this week.

Chip stocks and mega-cap tech continue to dominate the list. However, a rift is forming in cybersecurity stocks as Palo Alto Networks plummeted on weak guidance.

RUSSELL 2000
The Growth-Centric Russell 2000

The Russell 2000 Top 25 list (+12.16%) outperformed the Russell 2000 index (-0.79%).

There were 8 major changes to the list this week.

Healthcare continues to dominate as investors look for the next big winners in the space.

Top Dawg Of The Week 🐶

The Top 25 lists' Top Dawg was Ventyx Biosciences Inc, which rallied 172.76%. 📈

The small-cap pharmaceutical stock seemingly jumped this week on news that Point72 Asset Management L.P. and Steven Cohen have acquired millions of shares in the company. A 13G filing was made to indicate the parties own more than 5% of a company's total stock issuance. 📝

$VTYX is up 171.66% YTD.

Get In Touch

Have feedback on The Daily Rip? Shoot me (Tom Bruni) an email at [email protected]; I’d love to hear from you.

Want to sponsor this newsletter and reach hundreds of thousands of passionate investors and traders? Reach us here.

Disclaimer: Content, news, research, tools, and securities symbols are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here.